Active Platelet Derived Growth Factor D (PDGFD) Homo sapiens (Human) Active protein

PDGF-D; IEGF; SCDGF-B; Spinal Cord Derived Growth Factor B; Iris-expressed growth factor; Platelet-derived growth factor D, receptor-binding form/latent form

Add to Cart Distributors
Overview
Properties
  • Buffer Formulation20mM Tris, 150mM NaCl, pH8.0, containing 1mM EDTA, 1mM DTT, 0.01% SKL, 5% Trehalose and Proclin300.
  • Traits Freeze-dried powder, Purity > 90%
  • Isoelectric Point8.4
Share your citation Upload your experimental result Review Leave a message
Loading...

Share a new citation as an author

Upload your experimental result

Review

Please attach serial No. on instruction manual

Contact us

Please fill in the blank.

Name*
Organization
Address
E-mail address*
Telephone
Inquiry*
Verification code* CheckCode
  • Active Platelet Derived Growth Factor D (PDGFD) Packages (Simulation)
  • Active Platelet Derived Growth Factor D (PDGFD) Packages (Simulation)
  • APC919Hu01.png Figure. SDS-PAGE
  • Certificate ISO9001: 2008, ISO13485: 2003 Registered

Activity test

Platelet-derived growth factor D (PDGFD) is a protein that in humans is encoded by the PDGFD gene. The protein encoded by this gene is a member of the platelet-derived growth factor family. PDGF plays a significant role in blood vessel formation, the growth of blood vessels from already-existing blood vessel tissue, mitogenesis. PDGF also plays a role in embryonic development, cell proliferation, cell migration, and angiogenesis. Besides, Macrophage Erythroblast Attacher (MAEA) has been identified as an interactor of PDGFD, thus a binding ELISA assay was conducted to detect the interaction of recombinant human PDGFD and recombinant human MAEA. Briefly, PDGFD were diluted serially in PBS, with 0.01% BSA (pH 7.4). Duplicate samples of 100μL were then transferred to MAEA-coated microtiter wells and incubated for 2h at 37℃. Wells were washed with PBST and incubated for 1h with anti-PDGFD pAb, then aspirated and washed 3 times. After incubation with HRP labelled secondary antibody, wells were aspirated and washed 3 times. With the addition of substrate solution, wells were
incubated 15-25 minutes at 37℃. Finally, add 50µL stop solution to the wells and read at 450nm immediately. The binding activity of PDGFD and MAEA was shown in Figure 1, and this effect was in a dose dependent manner.
Figure. The binding activity of PDGFD with MAEA.

Figure. Western Blot

Usage

Reconstitute in 20mM Tris, 150mM NaCl (PH8.0) to a concentration of 0.1-1.0 mg/mL. Do not vortex.

Storage

Avoid repeated freeze/thaw cycles. Store at 2-8°C for one month. Aliquot and store at -80°C for 12 months.

Stability

The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.

Citations

  • In vitro gene silencing effect of chitosan/shRNA PDGF-D nanoparticles in breast cancerDOI: 10.12991/mpj.2017.21
  • Transforming Growth Factor-β3 Regulates Adipocyte Number in Subcutaneous White Adipose TissuePubmed: 30332637

Recommend products